The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...

Revology Cars’ latest creation—the 1969 Boss 429 Mustang—uses advanced engineering to revive Ford’s iconic Mustang ...

The next generation of investors will need to be “AI-fluent,” in a similar fashion to how analysts had to learn how to use ...

Opinion: From Greenland to glory-hunting money, “peace prizes,” and more, Trump’s addiction to excess is metastasizing into a ...

Emburse, the company defining Expense Intelligence through AI-powered travel and spend orchestration, today announced the launch of Invoice Tax Validation, a new capability that helps finance teams ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene ...

Stratasys Ltd. faces falling sales despite strong liquidity; margins may improve via manufacturing pivot, but profits likely ...

Modern vision-language models allow documents to be transformed into structured, computable representations rather than lossy text blobs.

Vanta reports 9 AI risks organizations must manage, focusing on sensitive data exposure, accountability, and compliance to ...

Signed Definitive Agreement: The Federated Node Agreement is executed and effective as of December 30, 2025, by both the ...